FIT-001
Kura Oncology, Inc.
Kura Oncology, Inc.
7 Hills Pharma, LLC
Memorial Sloan Kettering Cancer Center
KaliVir Immunotherapeutics
Actuate Therapeutics Inc.
Tel-Aviv Sourasky Medical Center
Xencor, Inc.
Nuvectis Pharma, Inc.
Pfizer
Tizona Therapeutics, Inc
Essen Biotech
A2 Biotherapeutics Inc.
University of Nebraska
Takeda
Kidney Cancer Research Bureau
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
Harvard Medical School (HMS and HSDM)
Elephas
University of Cambridge
Centre Hospitalier Universitaire de Besancon
Degron Therapeutics Co.
University Health Network, Toronto
AstraZeneca
Dana-Farber Cancer Institute
Coherus Oncology, Inc.
Massive Bio, Inc.
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
Hadassah Medical Organization
National Institutes of Health Clinical Center (CC)
University of Texas Southwestern Medical Center
A2 Biotherapeutics Inc.
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Delfi Diagnostics Inc.
A2 Biotherapeutics Inc.
Genentech, Inc.
Institut Bergonié
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
DEKA Biosciences
Columbia University
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Elevation Oncology
Pfizer